Pharma News

Alembic Pharmaceuticals Limited announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fluorouracil Injection, 2.5 g/50 mL (50 mg/mL), of Spectrum Pharmaceuticals, Inc. (Spectrum).

Veterinarian, immunologist, and molecular geneticist Dr. Kathy Meek and her team from the Michigan State University College of Veterinary Medicine have made a discovery that may have implications for therapeutic gene editing strategies, cancer diagnostics and therapies, and other aspects of biotechnology.

Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from happening, according to new research from UTHealth Houston.

The study, led by Sandipan Pati, MD, associate professor in the Department of Neurology with McGovern Medical School at UTHealth Houston, was recently published in NEJM Evidence, a publication of the New England Journal of Medicine.

Centers for Disease Control and Prevention (CDC) US researchers said that the Gambia children deaths are associated with syrup made by Maiden Pharmaceuticals. Their investigation strongly suggests that medications contaminated with diethylene glycol (DEG) or ethylene glycol (EG) imported into The Gambia led to this acute kidney injury (AKI) cluster among children.

Hetero group to invest Rs. 1000 crore in Andhra Pradesh to expand its pharmaceutical and specialist business, said Vamsi Krishna Bandi, Managing Director of Hetero.

There was Global Investors Summit 2023 organised at Visakhapatnam where he said, "We are committed to Andhra Pradesh and will continue to expand our presence here. We'll be investing about Rs 1,000 crore in Andhra Pradesh over the next two years to grow our pharmaceutical and specialty business. This will generate employment for a minimum of 3,000 people."

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Apixaban Tablets, 2.5 mg and 5 mg (USRLD: Eliquis® Tablets).

Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25 mg, 50 mg, and 100 mg.

It is bioequivalent to the reference listed drug product (RLD), Cozaar Tablets of Organon LLC. Granules now has a total of 54 ANDA approvals from US FDA (52 Final approvals and 2 tentative approvals).

Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited.

In association with IIHMR University, Jaipur, Rajasthan State Pollution Control Board organized a Workshop on Biomedical Waste Management Rules, 2016 for doctors and staff of SMS Medical College – Attached Hospitals" on Thursday, February 16, 2023. The workshop was held at the SMS Auditorium in Jaipur and was attended by more than 100 participants.